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Accepted 27 March 2016Background:Management of symptomatic cavernomas of the posterolateral thalamus is particularly challenging
due to their intimate relationship with the posterior limb of the internal capsule. The risk of continued observa-
tion and surgical resection is debilitating motor dysfunction. Traditional microsurgical approaches must be tai-
lored for each lesion and account for the unique and speciﬁc anatomic relationships of individual cavernomas.
Advances in neuronavigation, MRI, DTI, and tractography have improved the safety of these procedures. Unfor-
tunately, resection remains associated with a signiﬁcant risk of postoperative morbidity.
Case description: We present a case report of a 44 year-old male with a symptomatic posterolateral thalamic
cavernoma for which multiple microsurgical approaches were considered. Ultimately, a complete resection
was achieved through a minimally invasive approach with the Nico BrainPath tubular retractor (Indianapolis,
IN). Following a brief period of immediate postoperative right-sided hemiplegia, the patient had returned to
near neurologic baseline at short-term follow-up.
Conclusion:Webelieve this to be the ﬁrst report of a successful resection of a lesion in this anatomic locationwith
this technology. Tubular retractor-guided approaches may represent a valid alternative when addressing
cavernomas in this challenging region. Long-term follow-up and larger cases series are necessary to determine
if outcomes are comparable to those associated with traditional microsurgical approaches.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Themanagement of cavernomas of the thalamus and basal ganglia is
particularly challenging. Their proximity to, and sometimes involve-
ment with, the genu and posterior limb of the internal capsule results
in a signiﬁcant risk of debilitatingmotor dysfunction, even in the setting
of a relatively small hemorrhage [1–7]. Surgical resection is associated
with a high risk of neurologicmorbidity due to themanipulation and re-
traction of critical surrounding structures. Location in the dominant
hemisphere results in additional risk of resection due to the possibility
of a postoperative speech deﬁcit [8]. As a result, observation of these le-
sions is indicated when asymptomatic or when found incidentally.
Unfortunately, a small subset of these lesions will behave aggres-
sively, resulting in repeated hemorrhage and progressive neurologic
deﬁcit. Surgical resection in these cases is warranted to remove the fu-
ture risk of progressive dysfunction and the risk of life-threateningnetic resonance imaging;MEPs,
otentials.
nta), adumont2@tulane.edu
anuscript.
. This is an open access article underhemorrhage [8,9]. Goals of resection are complete removal of the
offending lesion and preservation of neurologic function at long-term
follow-up [9,10]. The surgical approach must be tailored on an individ-
ual basis and take into account the exact location of the cavernoma and
its relationship to surrounding structures. An array of microsurgical ap-
proaches have been used successfully in the treatment of these lesions.
Advances in image guidance, diffusion tensor imaging (DTI), and
tractography have allowed for more tailored and safer approaches to
these lesions.
A 44 year-old male with a dominant hemisphere cavernoma cen-
tered in the posterolateral thalamus and displacing the genu and poste-
rior limb of the left internal capsule presented on two separate
occasions with right-sided hemiparesis. The patient made a signiﬁcant
recovery in function and was referred for radiosurgery. Signiﬁcant
weakness and growth of the hematoma occurred at the time of the
third hemorrhage and surgical intervention was offered.
We present the ﬁrst report of a posterolateral thalamic cavernoma
successfully resected with the minimally invasive Nico BrainPath tubu-
lar retractor. Following a brief period of right hemiplegia and expressive
aphasia in the immediate postoperative period, the patient experienced
a rapid and dramatic recovery of neurologic function. At short-term
follow-up, he had returned to near baseline motor strength and his
aphasia was largely resolved. We believe that the tubular retractorthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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approaches for the management these challenging lesions. Obviously,
a larger series of patients and long-term follow-up are required to deter-
mine if results are comparable to those obtainedwith traditional micro-
surgical approaches.
2. Case report
2.1. Clinical history
A 44-year-old right-handedmale presented to the clinic 6weeks fol-
lowing the acute onset of mild right hand and legweakness. At the time
of presentation, theweakness had nearly resolved, however, the patient
was left with incoordination in his right hand. Noncontrasted head CT
demonstrated a mixed-density hemorrhagic mass in the lateral thala-
mus and posterior limb of the left internal capsule without surrounding
edema. Magnetic resonance imaging (MRI) showed a 1.72 × 1.96 cm
well-circumscribed mass and associated blood products consistent
with a hemorrhagic cavernoma (Fig. 1). A diagnostic angiogram was
negative for underlying vascular malformation. Observation was rec-
ommended, as the patient had made a near complete recovery.
Approximately 3 weeks after ﬁrst presentation, the patient present-
ed to the emergency room with new onset increased weakness in the
right upper (4−/5) and lower (4+/5) extremity. MRI demonstrated
an increase in the size of the lesion, which now measured
2.4 × 2.6 cm. DTI and tractography conﬁrmed that the mass was cen-
tered in the left lateral posterior thalamus and caused signiﬁcant lateral
displacement of the genu and posterior limb of the left internal capsule
(Fig. 2). The patient rapidly recovered to near baseline motor function
over the course of 48 h and he was referred for radiosurgery.
12 days later, prior to initiating radiotherapy, the patient presented a
third timewith 1/5 strength in the right hand, 3/5 strength in the prox-
imal right upper extremity, and 4/5 strength in the right lower extrem-
ity. He also had developed mild right facial weakness. MRI again
demonstrated a signiﬁcantly larger lesion, now with a clearly deﬁned
1.8 × 2.2 cm cavernoma and a surrounding 3.5 × 3 cm hematoma
(Fig. 3). The patient was counseled on the risk of permanent paralysis
with continued observation and radiosurgery. He was also informed of
the signiﬁcant risks of surgical resection, including, transient or perma-
nent right hemiparesis or plegia and aphasia. The patient and family
agreed to proceed with surgical resection.
2.2. Operative procedure
The patient was placed under general anesthesia and positioned su-
pine on the operating table. Mannitol was not administered andFig. 1.MRI at presentation following ﬁrst symptomatic hemorrhage. T1 (A) coronal and T2 (B)
products consistent with a hemorrhagic cavernoma. The cavernoma is centered in the lateral lnormocapnia was maintained until the obturator was passed through
thewhite matter, as which point mild hyperventilation was performed.
Neuromonitoring, including somatosensory evoked potentials (SSEPs)
and motor evoked potentials (MEPs), was performed throughout the
procedure. No identiﬁable left-sided MEPs were present with transcra-
nial stimulation through scalp electrodes.
The head was ﬁxed in the Mayﬁeld three-point clamp and posi-
tioned parallel to the ﬂoor. Using Stealth neuronavigation the
predetermined left frontal starting point was identiﬁed on the scalp. A
linear paramedian incision was planned over the starting point. A
small left frontal craniotomy was performed and an epidural lead was
placed over the left motor strip. Left-sided MEPs were identiﬁed in the
right deltoid and foot with stimulation through the epidural electrode.
A small dural incision was made over the starting point and the target
sulcus was identiﬁed. The sulcus was opened superﬁcially with an
arachnoid knife.
A 75 mm sheath was selected to traverse the 70 mm between the
frontal starting point and the posterior inferior margin of the
cavernoma. The obturator extends 15 mm beyond the distal end of
the sheath and this distance must be incorporated into the planning.
Using the Stealth navigation wand and obturator, the tubular retractor
was advanced into position and secured to the Greenberg retractor.
MEPs were immediately checked following trocar placement and the
right deltoid and foot signals could no longer be identiﬁed through epi-
dural stimulation.
The operating microscope was brought into the ﬁeld and the hema-
toma was easily identiﬁed within the tubular retractor (Fig. 4). The he-
matoma and pieces of the cavernoma were removed systematically
until the visualized ﬁeld was clear. The tube was then progressively
withdraw to allow additional hematoma and cavernoma to “fall” into
the ﬁeld. This process was repeated until the cavernoma and hematoma
had been completely resected. The right deltoid and foot MEPs did not
recover during the procedure, while SSEPs remained unchanged. Per-
manent section conﬁrmed a cavernoma and associated hematoma.
The patient awakened in the operating room with a complete right
hemiplegia, expressive aphasia, and a worsening right facial paralysis.
Within 12 hours the patient improved to a 3/5 strength in the right
upper extremity and 4−/5 strength in the right lower extremity. His fa-
cial weakness recovered to baseline over the following 48 h. At the time
of discharge 1week later, hewas ambulatingwith physical therapy. The
proximal right upper and lower extremities had improved to 4+/5
strength. Unfortunately, the right hand remained plegic. MRI performed
on postoperative day six demonstrated complete resection of the
cavernoma, although this will require conﬁrmation with repeat MRI in
3 to 6 months. Postoperative DTI and tractography demonstrated re-
duced mass effect on the posterior limb of the internal capsule (Fig. 5).axial MRI demonstrating a 1.72 × 1.96 cmwell-circumscribed lesion and associated blood
eft thalamus and posterior limb of the internal capsule.
Fig. 2.MRI, DTI, and tractography following second symptomatic hemorrhage. (A) Gradient echo MRI demonstrating a 2.4 × 2.6 cm well-circumscribed hemorrhagic lesion without
surrounding edema. (B) DTI shows the hemorrhage to be centered in the posterolateral thalamus. (C) Tractography conﬁrms the intimate association with the tracts of the genu and
posterior limb of the internal capsule, which are clearly displaced and bowed over the lateral margin of the hematoma.
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To the best of our knowledge, we report theﬁrst use of the BrainPath
tubular retractor system for the resection of a cavernoma centered in
the lateral thalamus and posterior limb of the internal capsule of the
dominant hemisphere. Despite a loss of weak baseline MEPs in the op-
erating room and an immediate postoperative hemiplegia, the patient
demonstrated a rapid recovery of motor function in the upper and
lower extremities. A moderate postoperative expressive aphasia had
largely resolved at the time of discharge. Cavernomas of the thalamus
and internal capsule present a challenging subset of lesions, for which
management remains somewhat controversial. The risk of motor paral-
ysis, and the potential speech deﬁcit associated with dominant hemi-
sphere lesions, once made these lesions largely inoperable.
Microsurgical technique and advances in neuronavigation have made
thedeep supratentorial anatomymore accessible. Theuse ofmodern tu-
bular retractors further increases the ease and speed of access, mini-
mizes brain retraction, and displaces, rather than disrupts, deep and
critical white matter tracts.Fig. 3.MRI following third symptomatic hemorrhage. Following the third presentation,
gradient echo MRI clearly demonstrated a distinct 1.8 × 2.2 cm cavernoma and a
3.5 × 3 cm surrounding hematoma.3.1. Natural history and potential for recovery
The annual hemorrhage risk for asymptomatic cavernomas ranges
between 0.39 and 4.2%, however, once symptomatic, the rebleed rate
rises to 22.9% per patient year [10–14]. These statistics are likely not en-
tirely reﬂective of the actual hemorrhage rate, but in part, indicative of
the proximity of symptomatic lesions to critical structures. Porter et al.
also highlighted the effect of location on the rate of hemorrhage [2]. In
170 patient-years of observation, 4.1% of deep lesions were observed
to bleed versus 0% of superﬁcial lesions. Further impacting the poor nat-
ural history of cavernomas located in eloquent anatomy, is the low like-
lihood of full spontaneous recovery following a hemorrhage. Wostrack
et al. reported a complete recovery following an initial hemorrhage in
only 6 of 45 (13%) patients [15]. In patients with neurologic deﬁcits
treated nonsurgically, Porter and colleagues reported approximately
two-thirds of patients achieved only partial or no recovery of function
[2]. Multiple authors have published similar results pertaining to long-
term outcome [16–19].3.2. Surgical results
As was the case with our patient, resection of cavernomas in elo-
quent regions is associated with a signiﬁcant risk of new or worsening
neurologic deﬁcits, particularly in the immediate postoperative period.
This initial deterioration is due tomanipulation and retraction of critical
structures and the resultant edema [9]. In our case, the edema within
the thalamus, internal capsule, and basal ganglia was clearly observed
on the immediate postoperative scan. Adequate patient counseling
prior to surgery is a key component of management in this case and
the patient should be prepared to awakenwith at least a transientwors-
ening in condition. Our patient and his familywere informed on the risk
of right hemiplegia and the potential for a partial aphasia.
At follow-up, it is important to recognize that many patients do
achieve a signiﬁcant recovery of function. Bertalanffy et al. reviewed
26 patients treated with microsurgical resection of deep-seated
cavernomas, 10 of which were located in the insula and basal ganglia
[20]. Seven patients experienced a delayed recovery of function, while
an additional eight suffered a signiﬁcant complication. Wostrack et al.
reported 47% of patients suffered a transient neurologic morbidity,
with brainstem cavernomas associated with the highest rate of new
neurologic deﬁcit [15]. Importantly, 90% of patients harboring eloquent
non-brainstem cavernomas had no new postoperative deﬁcit and 50%
of those patients exhibited improvement. In a series of 56 patients
with symptomatic brainstem, thalamic, and basal ganglia AVMs,
Steinberg et al. reported a worsened immediate postoperative neuro-
logic deﬁcit in 29% of patients. At the time of long-term follow-up,
only 5% had a signiﬁcant permanent deﬁcit and 52% had improved com-
pared to their presenting condition [9]. It is important to note that the
Fig. 4. Cavernoma resection with the Nico BrainPath tubular retractor. (A) Visualization of hematoma upon Stealth-guided placement of the Nico BrainPath sheath. (B) Resection of
cavernoma with bimanual microsurgical technique. (C) The surrounding white matter is observed following complete cavernoma resection.
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internal capsule due to the risk of permanent contralateral hemiplegia
[9]. Large lesions of the basal ganglia and thalamus that extended into
or displaced the posterior limb of the internal capsule were removed
with good outcomes [9].
3.3. Traditional microsurgical options
The vast majority of literature pertaining to deep-seated
supratentorial cavernomas is related to basal ganglia and thalamic le-
sions [3,8]. There is considerably less data in regards to cavernomas in-
timately associated with or within the posterior limb of the internal
capsule.Multiple surgical approaches to this region have been described
in the literature. The transsylvian transinsular approach is well-suited
for insular and lateral basal ganglia lesions [21,22]. Cavernomas cen-
tered in the superomedial thalamus may be managed via the anterior
interhemispheric contralateral transcallosal approach [23–25]. This ap-
proach is particularly appealing due to its avoidance of perforators and
dissection of the Sylvian ﬁssure. A transparietal transventricular ap-
proach allows for greater exposure of the lateral thalamus, but places
the optic radiations at risk [26–28].
Posterior lesions centered near themidline are accessed via the poste-
rior interhemispheric approach and its many variations [29]. The
subcallosal approach adds additional lateral exposure to posterior lesions
[9]. The supracerebellar infratentorial approach provides access to lesions
arising in the posterior inferior thalamus [30]. Multiple authors have also
described successful resection of posterior thalamic cavernomas through
a parietooccipital transventricular approach that utilizes access through
the pulvinar [3,8,9]. Transgression of the pulvinar has not resulted in sig-
niﬁcant morbidity in multiple reports [3,8,9].Fig. 5. Postoperative imaging. (A) Immediate postoperative head CT demonstrating complet
identiﬁed in the left thalamus, basal ganglia, and internal capsule. (B) Gradient echo MRI perf
hematoma.These traditional approaches were discussed for the cavernoma de-
scribed above, however, its locationdid notmake any one approach par-
ticularly suitable. Spetzler speciﬁcally warns about the signiﬁcant risk of
surgical resection of cavernomas in the lateral aspect of the posterior
thalamus [8]. The posterior limb of the internal capsule largely blocks
lateral access, while access to the lesion is restricted in midline ap-
proaches. He suggests transsylvian transinsular or parieto-occipital ap-
proaches in these cases, but advises careful consideration when
operating in the dominant hemisphere. In our case, the transsylvian
transinsular approachwas ruled out because it certainly would have re-
quired transgression of the ﬁbers of the genu or posterior limb of the in-
ternal capsule. The profound effect that each hemorrhage had onmotor
function, highlighted the intimate relationship between the lesion and
these motor ﬁbers. Additionally, DTI and tractography showed the
cavernoma and hematoma to be largely centered in the white matter
tracts of the internal capsule.
The anterior interhemispheric contralateral transcallosal approach
was not employed due to the signiﬁcant mass of thalamus between
the medial border of the lesion and the ventricle. The parietooccipital
transventricular approach was felt to place the visual ﬁbers, which are
completely unaffected by the mass, at risk. The risk of a speech deﬁcit
with this approach and the transsylvian approach, due to working in
the dominant hemisphere, was deemed high. The lesion did not ap-
proach the inferior thalamus, thus making the supracerebellar
infratentorial approach a poor option.
3.4. Image guidance
Advances in neuroimaging, including, high resolution MRI, DTI, and
tractography have allowed for a greater understanding of the operativee resection of left thalamic and internal capsule cavernoma. There is signiﬁcant edema
ormed on postoperative day six demonstrates complete resection of the cavernoma and
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corridor for resection. Monitoring of MEPs and SSEPs allow for real-
time feedback.
3.5. Tubular retractors
Tubular retractors, along with frame-based navigation, were ﬁrst
used by Kelly and colleagues for the resection of deep-seated tumors
[31–33] Advances in frameless stereotaxy have since led to the advent
of multiple frameless tubular retractor systems [31–36]. The Nico
BrainPath tubular sheath system has been shown to be safe and effec-
tive in its ability to access intracerebral hematomas located in deep-
seated or eloquent regions [37]. The obturator features a tapered end
which promotes displacement of the white matter tracts, rather than
transection, during advancement of the system to the target. This ap-
proach, ﬁrst described by Ritsma and colleagues, has been termed min-
imally invasive subcortical parafascicular transulcal access [37].
The sheath is manufactured in three lengths (50 mm, 60 mm,
75 mm) to allow for tailored access depending on the depth of individ-
ual lesions. All sheaths are a standardized 13.5 mm in diameter, which
allows for bimanual dissection and clear visualization through the oper-
atingmicroscope. The sheath is composed of clear plastic that allows for
visualization of the surrounding anatomy. Placement of the sheath at
the most inferior pole of the lesion holds overlying tissue out of the
ﬁeld of view and allows for the systemic clearing of pathology. Once
the visualized area has been cleared, the sheath is “backed-out” to
allow overlying lesional tissue to “fall” into the ﬁeld. This process is re-
peated until the pathology is resected and the sheath has been removed
beyond the most superﬁcial surface of the lesion. An estimation of the
involvement of surrounding tissue can be gleaned from direct visualiza-
tion through the clear sheath.
Compared to traditional microsurgical techniques, there are a num-
ber of important differences in technique that are critical to the success
of tubular retractor approaches. Whereas traditional microsurgical and
skull base approaches rely heavily on brain relaxation, resection with
a tubular retractor is aided by maintaining a “full” brain. Osmotic di-
uretics are avoided and normocapnia is maintained. These measures
prevent the brain from sagging, which increases the accuracy of
neuronavigation. We employ a brief period of hyperventilation just
prior to sheath and obturator insertion to account for the added volume
of the tube. The normal to slightly elevated intracranial pressure also
drives the lesion, particularly hematomas, into the sheath. This phe-
nomenon delivers the mass to the surgeon and limits dissection off of
critical structures. A small dural opening, only large enough to safely
pass the sheath without resistance, is also critical. The minimal opening
creates a seal around the tube that maintains the intracranial pressure
and stabilizes the sheath during resection.
We feel that the tubular sheath offered distinct advantages over tra-
ditional microsurgical approaches in this case. First, the sheath obviated
the need for dissection of the Sylvian and interhemisphericﬁssures. Sec-
ond, the selected trajectory passed medial to the arcuate fasciculus and
entered the hematoma cavity above the level of the majority of the in-
ternal capsular ﬁbers. Third, the hematoma largely delivered itself into
the tube and was easily removed with irrigation and gentle suction,
minimizingwhitematter dissection. Fourth, themaintenance of normal
to slightly increased intracranial pressure aided signiﬁcantly in hemo-
stasis. As the tube was progressively retracted, the white matter col-
lapsed on itself, thereby tamponading the cavity. Minimal bipolar
cautery was required, which is critical in eloquent areas. Finally, a
small craniotomy through a linear incision was all that was required
for adequate access. Operative time and blood loss was also limited to
approximately 2 h and 50 cm3, respectively.
There are certainly some disadvantages to the minimally invasive
approach employed in this case. Although the Nico BrainPath retractor
does allow for some “toggling” to view different areas of the resection
cavity, we speciﬁcally avoided this maneuver. Do the belief that wewere passing through at least some component of the genu and poste-
rior limb of the internal capsule, we did not want to apply undue tor-
sional stress to the critically important motor ﬁbers. Instead, we relied
entirely on the tendency of the lesion to “fall” into the ﬁeld and main-
tained a perpendicular orientation throughout the case. As a result, we
were somewhat limited in our ﬁeld of view, which could have led to in-
complete resection. Residual cavernomas in eloquent areas are known
to follow an aggressive course, resulting in repeated hemorrhage, en-
largement, and worsening neurologic deﬁcits [9,20]. Fortunately, post-
operative MRI is consistent with complete removal, but repeat
imaging at 3 to 6 months is required to conﬁrm curative resection.
The second main disadvantage of the sheath retractor was the long
tract that was required to reach the lesion. Without a doubt, the retrac-
tor passed through components of the basal ganglia and the displaced
ﬁbers of the internal capsule, which was reﬂected in the immediate
loss of weak MEPs. Although the sheath and obturator are speciﬁcally
designed to displace the ﬁbers, there is no way to quantify the damage,
or lack of damage, imposed during sheath placement. Additional studies
both in the lab and in clinical practice are required to better deﬁne this
variable.
3.6. Limitations
Clearly, additional patientswith similarly located lesionswill need to
be treated to determine the beneﬁt of the tubular retractor approach to
cavernomas of the posterior limb of the internal capsule. The rarity of
these lesionswillmake the accumulation of signiﬁcant data challenging.
Of course, we do not know if the outcome would have been improved
with traditional microsurgical resection. It is also important to point
out that this lesion was exhibiting a hemorrhage pattern consistent
with temporal clustering [38]. There is a possibility that the lesion
may have become less inclined to bleed with time, responded to radio-
surgery, and the patient would have made a signiﬁcant recovery. The
patient was counseled in regards to this option, but do to the aggressive
clinical course and progressive motor deﬁcit with each hemorrhage,
complete surgical resection was indicated.
4. Conclusion
Resection of cavernomas of the posterolateral thalamus, due to their
intimate relationship with the posterior limb of the internal capsule,
represent the greatest surgical challenge of the supratentorial deep-
seated cavernomas. The risk of signiﬁcantmorbidity is further increased
when located in the dominant hemisphere. In this case, successful com-
plete resection of the lesion was achieved with the minimally invasive
Nico BrainPath retractor. Although this retractor, and others like it,
have been used successfully with other lesion, this is the ﬁrst report of
a cavernoma resection in this very speciﬁc anatomic location. The pa-
tient experienced immediate postoperative deterioration, but improved
rapidly and has returned to near neurologic baseline at short-term
follow-up.We believe that theNico system represents a potential viable
surgical option when addressing these lesions. Long-term follow-up
and larger patient series will be necessary to determine if outcomes
are comparable to those achieved with traditional microsurgical
approaches.
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